Jyong Biotech Ltd (MENS)

10:44 AM

Jyong Biotech (NASDAQ:MENS) Shares Gap UpStill a Buy? - MarketBeat

10:44 AM

07:18 AM

Jyong Biotech: Speculative BPH And Prostate Cancer Prevention Story (NASDAQ:MENS) - Seeking Alpha

07:18 AM

Nov 26, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 9.6%What's Next? - MarketBeat

Nov 26, 2025

Nov 26, 2025

Taiwan's Jyong Biotech announces partnership in Korea to evaluate in‑licensing of plant-derived MCS drugs - BioSpectrum Asia

Nov 26, 2025

Nov 24, 2025

Jyong Biotech signs letter of intent with South Korean pharma company - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

Jyong Biotech to Evaluate Licensing Deal for MCS-2 Drug Candidate in South Korea - MarketScreener

Nov 24, 2025

Nov 24, 2025

Jyong Biotech signs letter of intent with South Korean pharma company By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs - The Manila Times

Nov 24, 2025

Nov 24, 2025

Jyong Biotech (Nasdaq: MENS) LOI to Evaluate MCS-2 Licensing with Korean Pharma - Stock Titan

Nov 24, 2025

Nov 21, 2025

Jyong Biotech (NASDAQ:MENS) Shares Up 10.9%Should You Buy? - MarketBeat

Nov 21, 2025

Nov 21, 2025

Jyong Biotech completes primary endpoint analysis for Phase II trial of MCS-8 - Yahoo Finance

Nov 21, 2025

Nov 21, 2025

Exploring Jyong Biotech’s (NasdaqGM:MENS) Valuation Following Recent Share Price Volatility - Yahoo Finance

Nov 21, 2025

Nov 20, 2025

Jyong Biotech reports positive results for prostate cancer drug in phase II trial - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Jyong Biotech stock soars after positive Phase II prostate cancer drug results - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Jyong Biotech stock soars after positive Phase II prostate cancer drug results By Investing.com - Investing.com South Africa

Nov 20, 2025

Nov 20, 2025

Jyong Biotech Says Phase 2 Trial of MCS-8 in Prostate Cancer Meets Efficacy Endpoints - MarketScreener

Nov 20, 2025

Nov 20, 2025

Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes - The Manila Times

Nov 20, 2025

Nov 20, 2025

Jyong Biotech (Nasdaq: MENS) MCS-8 Phase II Cuts Prostate Cancer 27%, High-Grade 17% - Stock Titan

Nov 20, 2025

Nov 19, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap DownTime to Sell? - MarketBeat

Nov 19, 2025

Nov 19, 2025

Jyong Biotech Ltd. (MENS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 19, 2025

Nov 19, 2025

Jyong Biotech is Now Oversold (MENS) - Nasdaq

Nov 19, 2025

Nov 18, 2025

Jyong Biotech plunges 49% after InvestingPro’s overvalued warning By Investing.com - Investing.com Australia

Nov 18, 2025

Nov 17, 2025

Google, Alibaba among market cap stock movers on Monday - Investing.com

Nov 17, 2025

Nov 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Nov 17, 2025

Nov 17, 2025

Google and Micron among market cap stock movers on Monday By Investing.com - Investing.com UK

Nov 17, 2025

Nov 17, 2025

Google and Micron among market cap stock movers on Monday - Investing.com India

Nov 17, 2025

Nov 13, 2025

Jyong Biotech (MENS US): Taiwan-Based, US-Listed, Excluded from US & Global Indices - Smartkarma

Nov 13, 2025

Nov 13, 2025

Jyong Biotech (NASDAQ:MENS) Trading Down 8%Here's Why - MarketBeat

Nov 13, 2025

Nov 12, 2025

Dow notches record-high close while tech-heavy Nasdaq slips - Yahoo Finance

Nov 12, 2025

Nov 11, 2025

Dow notches record high close, traders bet on end to shutdown - Yahoo Finance

Nov 11, 2025

Nov 10, 2025

Health insurers slide after subsidies dropped from US shutdown deal - Yahoo Finance

Nov 10, 2025

Nov 10, 2025

Global shares jump as investors eye potential end to US shutdown - Yahoo Finance

Nov 10, 2025

Nov 05, 2025

Wall Street ends higher on solid data, strong earnings - Yahoo Finance

Nov 05, 2025

Nov 03, 2025

OpenAI signs $38 billion deal to use Amazon's cloud platform - Yahoo Finance

Nov 03, 2025

Oct 31, 2025

'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - Yahoo Finance

Oct 31, 2025

Oct 30, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Up 11.2%Here's What Happened - MarketBeat

Oct 30, 2025

Oct 29, 2025

FLOWSERVE CORPORATION (FLS) Stock, Price, News, Quotes, Forecast and Insights - MSN

Oct 29, 2025

Oct 29, 2025

Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Benzinga

Oct 29, 2025

Oct 29, 2025

Caterpillar, Nvidia Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com Nigeria

Oct 29, 2025

Oct 29, 2025

Caterpillar, Nvidia Lead Market Cap Stock Movers on Wednesday - Investing.com India

Oct 29, 2025

Oct 29, 2025

Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results - Yahoo Finance

Oct 29, 2025

Oct 28, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 15.6%Here's Why - MarketBeat

Oct 28, 2025

Oct 28, 2025

Tesla and Nvidia lead market cap stock movers this Tuesday - Investing.com

Oct 28, 2025

Oct 28, 2025

Downgrade Sparks Sharp Fall in Jyong Biotech MENS Stock, Yet Support Holds - FXLeaders

Oct 28, 2025

Oct 27, 2025

Here's How Much Traders Expect Meta Stock To Move After Earnings This Week - Yahoo Finance

Oct 27, 2025

Oct 27, 2025

Tesla and Qualcomm Lead Monday’s Market Cap Stock Movers - Investing.com

Oct 27, 2025

Oct 27, 2025

Tesla and Qualcomm Lead Monday’s Market Cap Stock Movers By Investing.com - Investing.com UK

Oct 27, 2025

Oct 27, 2025

New Montreal Biotech LifeLore Pathways Launches to Accelerate Microbial Innovation - Yahoo Finance

Oct 27, 2025

Oct 26, 2025

Jyong Biotech's (MENS) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 26, 2025

Oct 24, 2025

BNB Jumps on CZ's Pardon - Yahoo Finance

Oct 24, 2025